Status:
RECRUITING
Tissue-engineered Skin Graft Repair of Autologous Scar Dermal Scaffolds
Lead Sponsor:
First Affiliated Hospital, Sun Yat-Sen University
Conditions:
Scar
Eligibility:
All Genders
Up to 80 years
Phase:
NA
Brief Summary
Hypertrophic scar is an inevitable outcome of wound repair. It affects the appearance and some scar contracture often leads to joint dysfunction.Patients have low quality of life, long treatment cycle...
Eligibility Criteria
Inclusion
- The patient is diagnosed as hypertrophic scar and needs surgical repair; The scar size was 10cm2 to 200cm2, and the site was not limited; Patients with stable vital signs and tolerable operation indicated by routine examination; Patients in good mental state, can follow the doctor's advice, regular return; Those whom the researchers considered unsuitable for inclusion; Patients have participated in this study at any time in the past; Those whom the researchers considered unsuitable for inclusion; Patients have participated in this study at any time in the past.
Exclusion
- Those who did not meet the inclusion criteria were found after the selected subjects; The follow-up time after inclusion was less than 2 times, and the objective efficacy could not be evaluated (but the adverse reactions could be evaluated); Subjects who violate protocol requirements.
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
226 Patients enrolled
Trial Details
Trial ID
NCT04389164
Start Date
March 1 2019
End Date
December 31 2027
Last Update
May 15 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China, 510080